1
|
Alashkar Alhamwe B, Yuskaeva K, Wulf F, Trinkmann F, Kriegsmann M, Thomas M, Keber CU, Strandmann EPV, Herth FJ, Kolahian S, Renz H, Muley T. Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC. Int J Mol Sci 2024; 25:9552. [PMID: 39273499 PMCID: PMC11395097 DOI: 10.3390/ijms25179552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 08/20/2024] [Accepted: 08/26/2024] [Indexed: 09/15/2024] Open
Abstract
Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potential impact of these comorbid immune responses on the survival rates of patients with NSCLC. Our retrospective study used data from the Data Warehouse of the German Center for Lung Research (DZL) and Lung Biobank at Thoraxklinik Heidelberg. We estimated the association of blood eosinophilia and neutrophilia on survival rates in an inflammatory cohort of 3143 patients with NSCLC. We also tested sensitization to food and inhalants and high-sensitivity C-reactive protein (hs-CRP) in a comorbidity cohort of 212 patients with NSCLC. Finally, we estimated the infiltration of immune-relevant cells including eosinophils, T-cells, and mast cells in a tissue inflammatory sub-cohort of 60 patients with NSCLC. Sensitization to at least one food or inhalant (sIgE) was higher in patients with adenocarcinoma (adeno-LC) than the non-adenocarcinoma (non-adeno-LC). Furthermore, hs-CRP was higher in non-adeno-LC compared with adeno-LC. Peripheral inflammation, particularly eosinophilia and neutrophilia, was associated with poor survival outcomes in NSCLC with a clear difference between histological subgroups. Finally, blood eosinophilia was paralleled by significant eosinophil infiltration into the peritumoral tissue in the lung. This study provides novel perspectives on the crucial role of peripheral inflammation, featuring eosinophilia and neutrophilia, with overall survival, underscoring distinctions between NSCLC subgroups (adeno-LC vs. non-adeno-LC). Peripheral eosinophilia enhances eosinophil infiltration into tumors. This sheds light on the complex interplay between inflammation, eosinophil infiltration, and NSCLC prognosis among various histological subtypes. Further studies are required to underscore the role of eosinophils in NSCLC among different histological subgroups and their role in shaping the tumor microenvironment.
Collapse
Affiliation(s)
- Bilal Alashkar Alhamwe
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
- Institute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University Marburg, 35043 Marburg, Germany
- College of Pharmacy, International University for Science and Technology (IUST), Daraa 15, Syria
| | - Kadriya Yuskaeva
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Translational Research Unit (STF), Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Friederike Wulf
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Frederik Trinkmann
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Pneumology and Respiratory Medicine, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
- Department of Biomedical Informatics (DBMI), Center for Preventive Medicine and Digital Health Baden-Württemberg (CPD-BW), University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, 69117 Heidelberg, Germany
| | - Mark Kriegsmann
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Institute of Pathology, University Hospital Heidelberg, Pathology Wiesbaden, Ludwig-Erhard-Str. 100, 65199 Wiesbaden, Germany
| | - Michael Thomas
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Oncology, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Corinna Ulrike Keber
- Institute for Pathology, University Hospital Giessen and Marburg, 35037 Marburg, Germany
| | - Elke Pogge von Strandmann
- Institute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University Marburg, 35043 Marburg, Germany
| | - Felix J Herth
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Pneumology and Respiratory Medicine, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Saeed Kolahian
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Harald Renz
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Thomas Muley
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Translational Research Unit (STF), Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| |
Collapse
|
2
|
Carneiro BGMC, Petroianu A, Machado JAN, Dos Anjos PMF, da Silva FR, Alberti LR, Resende V, Barrientos SC. Clinical and immunological allergy assessment in cancer patients. Sci Rep 2021; 11:18110. [PMID: 34518597 PMCID: PMC8437967 DOI: 10.1038/s41598-021-97200-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2021] [Accepted: 08/10/2021] [Indexed: 01/01/2023] Open
Abstract
Cancer is associated with immunodeficiency, while allergies result from immune system hyperactivity mediated by cytokines and immunoglobulins. The purpose of this study was to determine the relationship between immune environment of specific cancers and allergies, emphasizing cytokines related to Th1 and Th2 responses associated with IgE. 80 adults were distributed into two groups: control (n = 20) and cancer (n = 60), distributed in three subgroups (n = 20), head and neck, stomach, and prostate cancers. This study compared Th1 (IL-2) and Th2 (IL-4) parameters, anti-inflammatory, pro-inflammatory, or regulatory profile regarding both IgE levels and reported allergies, by means of clinical manifestations and IgE, IL-1β, IL-2, IL-4, IL-17, and TGF-β serum concentration. Clinically allergies were observed in 50% of the control group and in 20% of the cancer group (p = 0.009). IL-2 cytokine and TGF-β concentrations were higher in the patients with cancer as compared to the control (p < 0.005). However, there were IL-4, IL-17, and IL-1β decreases in the patients with cancer (p < 0.05). No correlation was observed between the cytokines studied and IgE and clinically proven allergies in both investigated groups. There was an inverse association between cancer and clinical allergy manifestations. In head and neck, stomach, and prostate cancers, an immunosuppressive serum tumor environment was predominant. There was no difference in cytokines related to Th1 and Th2 parameters in relation to IgE. No correlation was found between clinically proved allergies and immunity markers related to the same allergens.
Collapse
Affiliation(s)
- Bruno Gustavo Muzzi Carvalho Carneiro
- Service of Oncology of the Alberto Cavalcanti Hospital of the Hospital Foundation of the State of Minas Gerais, Rua Rio Claro 235, ap 401, Belo Horizonte, MG, 30411-235, Brazil.
| | - Andy Petroianu
- Surgery Department of the School of Medicine of the Federal University of Minas Gerais, Belo Horizonte, Brazil
| | | | | | | | - Luiz Ronaldo Alberti
- Surgery Department of the School of Medicine of the Federal University of Minas Gerais, Belo Horizonte, Brazil
| | - Vivian Resende
- Surgery Department of the School of Medicine of the Federal University of Minas Gerais, Belo Horizonte, Brazil
| | - Sofia Candia Barrientos
- Surgery Department of the School of Medicine of the Federal University of Minas Gerais, Belo Horizonte, Brazil
| |
Collapse
|
3
|
Wallace AD, Francis SS, Ma X, McKean-Cowdin R, Selvin S, Whitehead TP, Barcellos LF, Kang AY, Morimoto L, Moore TB, Wiemels JL, Metayer C. Allergies and Childhood Acute Lymphoblastic Leukemia: A Case-Control Study and Meta-analysis. Cancer Epidemiol Biomarkers Prev 2018; 27:1142-1150. [PMID: 30068517 PMCID: PMC6628274 DOI: 10.1158/1055-9965.epi-17-0584] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Revised: 10/30/2017] [Accepted: 07/25/2018] [Indexed: 12/22/2022] Open
Abstract
Background: Allergic disease is suspected to play a role in the development of childhood acute lymphoblastic leukemia (ALL). Studies conducted over the last several decades have yielded mixed results.Methods: We examined the association between allergy, a common immune-mediated disorder, and ALL in the California Childhood Leukemia Study (CCLS), a case-control study of 977 children diagnosed with ALL and 1,037 matched controls (1995-2015). History of allergies in the first year of life was obtained from interviews, mainly reported by mothers. Logistic regression analyses were conducted to estimate ORs and 95% confidence intervals (CIs), controlling for birth order, daycare attendance, and mode of delivery. In addition, we conducted meta-analyses with data from the CCLS and 12 published studies and employed a new method to estimate between-study heterogeneity (R_b).Results: Overall, no associations were observed between childhood ALL risk and specific allergy phenotypes or any allergy, as a group. However, having any allergy was associated with an increased risk of ALL among the youngest study participants. In the meta-analysis random-effects models, reduced odds of ALL were associated with hay fever (metaOR = 0.65; 95% CI, 0.47-0.90); however, restricting the analysis to studies that used medical records for assessment of allergy or recently published studies led to null or attenuated results.Conclusions: Overall, our findings do not support a clear association between allergy and childhood ALL.Impact: The degree to which epidemiologic studies can inform the relationship between allergies and risk of childhood ALL is limited by R_b. Cancer Epidemiol Biomarkers Prev; 27(10); 1142-50. ©2018 AACR.
Collapse
Affiliation(s)
- Amelia D Wallace
- School of Public Health, University of California, Berkeley, Berkeley, California.
| | - Stephen S Francis
- School of Community Health Sciences, University of Nevada, Reno, Nevada
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California
| | - Xiomei Ma
- Department of Epidemiology and Public Health, Yale University, New Haven, Connecticut
| | - Roberta McKean-Cowdin
- Preventive Medicine, University of Southern California, Los Angeles, Los Angeles, California
| | - Steve Selvin
- School of Public Health, University of California, Berkeley, Berkeley, California
| | - Todd P Whitehead
- School of Public Health, University of California, Berkeley, Berkeley, California
| | - Lisa F Barcellos
- School of Public Health, University of California, Berkeley, Berkeley, California
| | - Alice Y Kang
- School of Public Health, University of California, Berkeley, Berkeley, California
| | - Libby Morimoto
- School of Public Health, University of California, Berkeley, Berkeley, California
| | - Theodore B Moore
- School of Medicine, Pediatrics, University of California, Los Angeles, Los Angeles, California
| | - Joseph L Wiemels
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California
| | - Catherine Metayer
- School of Public Health, University of California, Berkeley, Berkeley, California
| |
Collapse
|
4
|
Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiol Biomarkers Prev 2017; 26:998-1007. [PMID: 28377416 DOI: 10.1158/1055-9965.epi-17-0003] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2017] [Revised: 01/27/2017] [Accepted: 03/03/2017] [Indexed: 11/16/2022] Open
Abstract
Background: Elevated keratinocyte carcinoma risk is present with several immune-related conditions, e.g., solid organ transplantation and non-Hodgkin lymphoma. Because many immune-related conditions are rare, their relationships with keratinocyte carcinoma have not been studied.Methods: We used Medicare claims to identify cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) cases in 2012, and controls matched on sex and age. All subjects were aged 65 to 95 years, of white race, and had attended ≥1 dermatologist visit in 2010-2011. Immune-related conditions were identified during 1999-2011 using Medicare claims. Associations were estimated with logistic regression, with statistical significance determined after Bonferroni correction for multiple comparisons.Results: We included 258,683 SCC and 304,903 BCC cases. Of 47 immune-related conditions, 21 and 9 were associated with increased SCC and BCC risk, respectively. We identified strongly elevated keratinocyte carcinoma risk with solid organ transplantation (SCC OR = 5.35; BCC OR = 1.94) and non-Hodgkin lymphoma (SCC OR = 1.62; BCC OR = 1.25). We identified associations with common conditions, e.g., rheumatoid arthritis [SCC OR = 1.06, 95% confidence interval (95% CI), 1.04-1.09] and Crohn's disease (SCC OR = 1.33, 95% CI, 1.27-1.39; BCC OR = 1.10, 95% CI, 1.05-1.15), and rare or poorly characterized conditions, e.g., granulomatosis with polyangiitis (SCC OR = 1.88; 95% CI, 1.61-2.19), autoimmune hepatitis (SCC OR = 1.81; 95% CI, 1.52-2.16), and deficiency of humoral immunity (SCC OR = 1.51, 95% CI, 1.41-1.61; BCC OR = 1.22, 95% CI, 1.14-1.31). Most conditions were more positively associated with SCC than BCC. Associations were generally consistent regardless of prior keratinocyte carcinoma history.Conclusions: Many immune-related conditions are associated with elevated keratinocyte carcinoma risk and appear more tightly linked to SCC.Impact: Immunosuppression or immunosuppressive treatment may increase keratinocyte carcinoma risk, particularly SCC. Cancer Epidemiol Biomarkers Prev; 26(7); 998-1007. ©2017 AACR.
Collapse
Affiliation(s)
- Elizabeth L Yanik
- Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
| | - Ruth M Pfeiffer
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - D Michal Freedman
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - Martin A Weinstock
- Department of Dermatology and Department of Epidemiology, Brown University, Providence, Rhode Island
| | - Elizabeth K Cahoon
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - Sarah T Arron
- Department of Dermatology, University of California, San Francisco, California
| | | | - M Kari Connolly
- Department of Dermatology, University of California, San Francisco, California
| | | | - Eric A Engels
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| |
Collapse
|
5
|
Nigro EA, Brini AT, Yenagi VA, Ferreira LM, Achatz-Straussberger G, Ambrosi A, Sanvito F, Soprana E, van Anken E, Achatz G, Siccardi AG, Vangelista L. Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice. THE JOURNAL OF IMMUNOLOGY 2016; 197:2583-8. [DOI: 10.4049/jimmunol.1601026] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2016] [Accepted: 08/11/2016] [Indexed: 11/19/2022]
|
6
|
Natsuga K, Cipolat S, Watt FM. Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility. J Invest Dermatol 2016; 136:99-106. [PMID: 26763429 PMCID: PMC4759621 DOI: 10.1038/jid.2015.383] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2015] [Revised: 07/24/2015] [Accepted: 09/11/2015] [Indexed: 12/11/2022]
Abstract
Mice lacking three epidermal barrier proteins-envoplakin, periplakin, and involucrin (EPI-/- mice)-have a defective cornified layer, reduced epidermal γδ T cells, and increased dermal CD4(+) T cells. They are also resistant to developing skin tumors. The tumor-protective mechanism involves signaling between Rae-1 expressing keratinocytes and the natural killer group 2D receptor on immune cells, which also plays a role in host defenses against infection. Given the emerging link between bacteria and cancer, we investigated whether EPI-/- mice have an altered skin microbiota. The bacterial phyla were similar in wild-type and EPI-/- skin. However, bacteria were threefold more abundant in EPI-/- skin and penetrated deeper into the epidermis. The major epithelial defense mechanism against bacteria is production of antimicrobial proteins (AMPs). EPI-/- skin exhibited enhanced expression of antimicrobial peptides. However, reducing the bacterial load by antibiotic treatment or breeding mice under specific pathogen-free conditions did not reduce AMP expression or alleviate the abnormalities in T-cell populations. We conclude that the atopic characteristics of EPI-/- skin are a consequence of the defective barrier rather than a response to the increased bacterial load. It is therefore unlikely that the increase in skin microbiota contributes directly to the observed cancer resistance.
Collapse
Key Words
- amp, antimicrobial protein
- epi-/- mice, mice lacking envoplakin, periplakin, and involucrin
- fish, fluorescence in situ hybridization
- mpo, myeloperoxidase
- nkg2d, natural killer group 2d
- spf, specific pathogen free
- tpa, tetradecanoylphorbol-13-acetate
- wt, wild-type
Collapse
Affiliation(s)
- Ken Natsuga
- Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom; Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Sara Cipolat
- Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom; Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom
| | - Fiona M Watt
- Centre for Stem Cells and Regenerative Medicine, King's College London, London, United Kingdom.
| |
Collapse
|